Bioceltix S.A. (BCX.WA)

PLN 79.8

(4.04%)

Total Liabilities Summary of Bioceltix S.A.

  • Bioceltix S.A.'s latest annual total liabilities in 2023 was 2.26 Million PLN , down -9.35% from previous year.
  • Bioceltix S.A.'s latest quarterly total liabilities in 2024 Q2 was 7.11 Million PLN , up 118.06% from previous quarter.
  • Bioceltix S.A. reported annual total liabilities of 2.5 Million PLN in 2022, up 13.93% from previous year.
  • Bioceltix S.A. reported annual total liabilities of 2.19 Million PLN in 2021, up 48.44% from previous year.
  • Bioceltix S.A. reported quarterly total liabilities of 7.11 Million PLN for 2024 Q2, up 118.06% from previous quarter.
  • Bioceltix S.A. reported quarterly total liabilities of 2.26 Million PLN for 2023 FY, down -9.35% from previous quarter.

Annual Total Liabilities Chart of Bioceltix S.A. (2023 - 2018)

Historical Annual Total Liabilities of Bioceltix S.A. (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 2.26 Million PLN -9.35%
2022 2.5 Million PLN 13.93%
2021 2.19 Million PLN 48.44%
2020 1.47 Million PLN 11.81%
2019 1.32 Million PLN -23.41%
2018 1.72 Million PLN 0.0%

Peer Total Liabilities Comparison of Bioceltix S.A.

Name Total Liabilities Total Liabilities Difference
BIOTON S.A. 215.86 Million PLN 98.949%
Captor Therapeutics Spolka Akcyjna 28.07 Million PLN 91.919%
Mabion S.A. 90.47 Million PLN 97.493%
Molecure S.A. 11.34 Million PLN 80.003%
NanoGroup S.A. 1.49 Million PLN -52.244%
Pharmena S.A. 1.9 Million PLN -19.023%
Poltreg S.A. 39.58 Million PLN 94.269%
Pure Biologics Spólka Akcyjna 20.84 Million PLN 89.117%
Ryvu Therapeutics S.A. 120.36 Million PLN 98.115%
Synthaverse S.A. 153.26 Million PLN 98.52%
Urteste S.A. 1.85 Million PLN -22.295%